-
2024 COMB丨Dr. Songqing Ye: Exploring the Development of CDK4/6 Inhibitors, ADCs, and Immunotherapy in Early-Stage Breast Cancer
From August 2-4, 2024, the 7th Oncology Precision Diagnosis and Treatment Conference and the 10th Breast Cancer Individualized Treatment Conference (COMB), organized by the China Cancer Foundation and Beijing Breast Disease Prevention Society, was grandly held in Beijing. The conference brought together the latest advances in individualized precision treatment for breast cancer in China, providing…
-
2024 ESMO BC | Exploratory Analysis of the SERENA-2 Study Suggests Early Changes in ctDNA Predict Better Response to Camizestrant Treatment
The SERENA-2 study evaluated the efficacy and safety of different doses of Camizestrant (75 mg, 150 mg) compared to fulvestrant in patients with advanced ER+/HER2- breast cancer. The results showed that the median PFS in the Camizestrant groups was similar regardless of ESR1m status or dosage. Researchers further conducted an exploratory analysis of the SERENA-2…
-
JCO | Is It Too Early to Use Radiographic Progression-Free Survival as a Surrogate Endpoint in Metastatic Hormone-Sensitive Prostate Cancer?
Metastatic hormone-sensitive prostate cancer (mHSPC) is a heterogeneous disease state and represents a critical time window for improving survival in advanced prostate cancer, requiring comprehensive and personalized treatment. As diagnostic and therapeutic strategies continue to advance, the management and assessment of mHSPC have become increasingly complex. Several studies have already evaluated the efficacy of new…
-
ASCO 2024| Meta-Analysis of Short-Term Recurrence Risk in HR+/HER2- Early Breast Cancer Patients Undergoing Endocrine Therapy
Multiple studies have demonstrated that both lymph node-positive and lymph node-negative stage II or III HR+/HER2- early breast cancer patients are at risk of recurrence, and the recurrence rate gradually increases over time. At the 2024 ASCO conference, a study conducted a systematic literature review and meta-analysis to evaluate the 3-year and 5-year recurrence risk…
-
Dr. Qiang Liu: Can Triple-Negative Breast Cancer Be Treated Without Chemotherapy?—Exploring Precision Medicine Guided by Biomarkers in Breast Cancer
In recent years, significant advancements have been made in the treatment of triple-negative breast cancer (TNBC), particularly in the field of biomarker research. To delve deeper into this, Cancer Outlook invited Dr. Qiang Liu from Sun Yat-sen Memorial Hospital, Sun Yat-sen University to provide an in-depth analysis of two recent landmark studies. These studies explore…
-
The 5th Lymphoma & Myeloma Immunotherapy and Targeted Therapy Conference | Dr. Kai Fu Discusses Research Progress and a New Prognostic Model in the North American Mantle Cell Lymphoma Program (NAMCLP)
On July 20, 2024, the 5th Lymphoma & Myeloma Immunotherapy and Targeted Therapy Conference, part of the Gaobo Medical Academic Conference, was successfully held in Beijing. With the core themes of “Precision, Integration, and Innovation,” the conference closely followed the latest developments and cutting-edge topics from the 29th Annual Congress of the European Hematology Association…
-
International Lung Cancer Conference | Dr. Yuehong Wang: Exploring a New Model for Comprehensive Lung Cancer Management in the AI Era
At the International Lung Cancer Conference (CLC 2024) held from August 9-11, Dr. Yuehong Wang from The First Affiliated Hospital, Zhejiang University School of Medicine delivered a keynote presentation titled “Exploring a New Model for Comprehensive Lung Cancer Management in the AI Era.” This article provides a brief overview of her report.
-
International Lung Cancer Conference | Dr. Nan Bi: Optimizing MRIgART Processes to Improve the Treatment of Brain Metastases in Lung Cancer
Radiation therapy plays a crucial role in the treatment of brain metastases from lung cancer. At the recent International Lung Cancer Conference (CLC 2024), Dr. Nan Bi from the Cancer Hospital , Chinese Academy of Medical Sciences and Peking Union Medical College, delivered a keynote presentation titled “Advances in Precision Radiotherapy for Brain Metastases in…
Connecting Medical Expertise through Media